Cargando…

A method for non-overlapping identification of human myeloid derived suppressor cells

Detalles Bibliográficos
Autores principales:	Gustafson, Michael, Lin, Yi, Maas, Mary, Gastineau, Dennis, Dietz, Allan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288485/ http://dx.doi.org/10.1186/2051-1426-2-S3-P150

Ejemplares similares

A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans
por: Gustafson, Michael P., et al.
Publicado: (2015)

Ten-color, whole blood flow cytometric analysis of human myeloid subsets; implications for immune monitoring in cancer patients
por: Gustafson, Michael P, et al.
Publicado: (2013)

Using whole immune system characterization (immune profiling) to identify immune biomarkers to determine patient selection, dosing, and efficacy of new immune therapies
por: Gustafson, Michael, et al.
Publicado: (2015)

Lymphoma monocyte crosstalk via HSP27 to promote immune suppression and chemotherapy resistance
por: Zhang, Zhe, et al.
Publicado: (2014)

Tumor monocyte cross talk promotes lymphoma cell resistance to chemotherapy
por: Zhang, Zhe (Jenny), et al.
Publicado: (2013)

Expression profiling of suppressive monocytes (CD14+HLA-DRlow/neg) in cancer patients
por: Cordes, Stefan F, et al.
Publicado: (2013)

Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress
por: Lin, Yi, et al.
Publicado: (2014)

The CD4+/CD14+HLA-DRlo/neg ratio as a prognostic biomarker in cancer patients
por: Dietz, Allan B, et al.
Publicado: (2013)

Motolimod, a selective TLR8 agonist induces apoptosis in monocytic myeloid-derived suppressor cells (M-MDSC)
por: Rutnam, Zina J, et al.
Publicado: (2015)

Bone marrow-derived progenitor cells develop into myeloid-derived suppressor cells at metastatic sites
por: Giles, Amber, et al.
Publicado: (2013)

Glioma microenvironment-derived CCL2 recruits regulatory T cells and myeloid-derived suppressor cells
por: Chang, Alan L, et al.
Publicado: (2015)

Hepatic myeloid-derived suppressor cells in tumor bearing mice exacerbate hepatitis and transform into pro-inflammatory myeloid cells
por: Medina-Echeverz, Jose, et al.
Publicado: (2013)

Interrogating the interactions between myeloid derived suppressor cells and cancer stem cells in glioblastoma
por: Otvos, Balint, et al.
Publicado: (2013)

0097. Myeloid-derived suppressor cells attenuate inflammation and improve the survival of microbial sepsis
por: Tong, L, et al.
Publicado: (2014)

ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth
por: Kohanbash, Gary, et al.
Publicado: (2014)

Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance
por: Zhang, Zhe (Jenny), et al.
Publicado: (2015)

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells
por: Vollbrecht, T, et al.
Publicado: (2012)

Independent mechanisms of T cell-suppression by subpopulations of myeloid-derived suppressor cells (MDSC) in tumor-bearing hosts
por: Raber, Patrick L, et al.
Publicado: (2013)

Dendritic cells inhibit myeloid-derived suppressor cells infiltration and function in mouse B16 melanoma microenvironment
por: Xia, Siyuan, et al.
Publicado: (2013)

High frequency of myeloid-derived suppressor cells in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases
por: Janols, H, et al.
Publicado: (2014)

Phosphatidylserine-targeting antibody induces M1 macrophage polarization, promotes myeloid derived suppressor cell differentiation and boosts tumor-specific immunity
por: Huang, Xianming, et al.
Publicado: (2013)

Proangiogenic neutrophilic-myeloid-derived suppressor cells emerge via two parallel pathways in renal cell carcinoma and melanoma
por: Ko, Jennifer, et al.
Publicado: (2013)

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity
por: Mao, Yumeng, et al.
Publicado: (2014)

Study of circulating myeloid derived suppressor cells (MDSC) in patients with breast cancer undergoing neo-adjuvant chemotherapy; interim results
por: Wesolowski, Robert, et al.
Publicado: (2013)

Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy
por: Eissler, Nina, et al.
Publicado: (2014)

Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors
por: Highfill, Steven L, et al.
Publicado: (2013)

Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells
por: Payne, Kyle K, et al.
Publicado: (2013)

Semaphorin 4D produced by human head and neck squamous cell carcinoma induces myeloid derived suppressor cells expansion from peripheral blood monocytes
por: Younis, Rania H, et al.
Publicado: (2015)

Targeted TLR9-activation/STAT3-blocking abrogates immunosuppressive functions of myeloid-derived suppressor cells from late-stage prostate cancer patients
por: Md Sakib Hossain, Dewan, et al.
Publicado: (2014)

Frequencies of circulating myeloid derived suppressor cells and dendritic cells in Egyptian patients with chronic Hepatitis C Virus infection undergoing treatment with IFN-α-based therapy
por: Salem, Mohamed L, et al.
Publicado: (2013)

Role of myeloid derived suppressor cells in tuberculosis infection and disease
por: Kumar, Nathella Pavan, et al.
Publicado: (2014)

Ganglioside containing nano-proteoliposome dampens myeloid-derived suppressor cells function and ability to cross-present tumor antigens: a new approach to recover CTL function on tumor bearing individuals
por: Fernández, Audry, et al.
Publicado: (2013)

P982: MYELOID-DERIVED SUPPRESSOR CELLS: CHARACTERIZATION IN PERIPHERAL BLOOD AND SPLEEN TISSUE OF PATIENTS WITH MYELOFIBROSIS
por: Campanelli, R., et al.
Publicado: (2022)

Muci specific IGE to modify myeloid derived cells of the tumor microenvironment
por: Mollick, J, et al.
Publicado: (2013)

Defining the overlap between sporadic and attenuated familial adenoma risk
por: Tuohy, Thérèse M, et al.
Publicado: (2011)

Juvenile overlap myositis: retrospective study about 20 cases
por: Piccolo, Vanessa Remy, et al.
Publicado: (2014)

Effect of infliximab in sweet’s syndrome-pyoderma gangraenosum overlap syndrome
por: Mahler, Birgitte, et al.
Publicado: (2014)

Lung cancer recruitment of CD14+ cells results in an immunosuppressive phenotype and improved tumor survival under stress conditions
por: Schenk, Erin, et al.
Publicado: (2015)

Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma
por: Markovic, Svetomir N, et al.
Publicado: (2006)

P752: TRANSCRIPTOMIC ANALYSIS OF MYELOID-DERIVED SUPPRESSOR CELLS (MDSCS) IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA (CIN)
por: Bizymi, Nikoleta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j0jq3vgnchdbgmmpj3bq105ao5